Hepatic stellate cells activation and liver fibrosis after chronic administration of ethanol

1. Ajakaiye M et al.: Alcohol and hepatocyte-Kupffer cell interaction (review). Mol Med Rep., 4,4, 2011: 597-602, doi: 10.3892/mmr.2011.471.10.3892/mmr.2011.471Search in Google Scholar

2. Bąk M. et al.: Toksyczne uszkodzenie wątroby - współczesny pogląd na etiopatogenezę. Część I. (Toxic liver injuries - a current view on pathogenesis. Part I. Medycyna Pracy, 62,1, 2011:47-55.Search in Google Scholar

3. Bioulac-Sage P., Balabaud Ch.: Proliferation and phenotypic expression of perisinusoidal cells. Journal of Hepatology, 15, 1992: 284-287.10.1016/0168-8278(92)90057-VSearch in Google Scholar

4. Britton R.S., Bacon B.R.: Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterology, 41, 4, 1994: 343-348.Search in Google Scholar

5. Burt AD, et al.: Ultrastructural localization of extracellular matrix proteins in liver biopsies using ultracryomicrotomy and immuno-gold labelling. Histopathology, 16,1, 1990:53-58.10.1111/j.1365-2559.1990.tb01060.x2307416Search in Google Scholar

6. Carpino G et al.: Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. Dig Liver Dis., 37, 5, 2005: 349-356.10.1016/j.dld.2004.11.00915843085Search in Google Scholar

7. Chedid A. et al.: Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. Am J Gastroenterol., 86, 2,1991: 210-216.Search in Google Scholar

8. Conde de la Rosa L., Moshage H., Nieto N.: Hepatocyte oxidant stress and alcoholic liver disease. Rev Esp Enferm Dig., 100, 2008:156-163.10.4321/S1130-01082008000300006Search in Google Scholar

9. De Minicis S., Brenner D.A.: Oxidative stress in alcoholic liver disease: role of NADPH oxidase complex. J Gastroenterol Hepatol., 23, 1, 2008: S98-S103.10.1111/j.1440-1746.2007.05277.x18336675Search in Google Scholar

10. Flisiak R., Wiercińska Drapało A., Tynecka E.: Transforming growth factor beta in pathogenesis of liver diseases. Wiad Lek., 53, 9-10, 2000:530-537.Search in Google Scholar

11. Friedman S.L.: Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev., 88, 1, 2008: 125-172, doi: 10.1152/physrev.00013.2007.10.1152/physrev.00013.2007288853118195085Search in Google Scholar

12. Fujii H., Kawada N.: Fibrogenesis in alcoholic liver disease. World J Gastroenterol., 7, 20, 25, 2014: 8048-8054. doi: 10.3748/wjg.v20.i25.8048.10.3748/wjg.v20.i25.8048408167525009376Search in Google Scholar

13. Gressner A.M.: Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts - a key event in hepatic fibrogenesis. Kidney Int Suppl., 54, 1996: S39-S45.Search in Google Scholar

14. Ionescu A.G. et al.: Histopathological and immunohistochemical study of hepatic stellate cells in patients with viral C chronic liver disease. Rom J Morphol Embryol., 54,4, 2013:983-991.Search in Google Scholar

15. Kasztelan-Szczerbińska B. et al.: Komórki gwiaździste jako główny regulator sygnalizacji międzykomórkowej w procesie włóknienia wątroby. (Stellate cells as a central regulator of intracellular signaling in the process of liver fibrosis). Postępy Nauk Medycznych, 1, 2010:69-74.Search in Google Scholar

16. Kisseleva T. et al.: Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci U S A, 12,109, 24, 2012: 9448-9453, doi: 10.1073/pnas.1201840109.10.1073/pnas.1201840109338611422566629Search in Google Scholar

17. Kmieć Z.: Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol.,161, III-XIII, 2001: 1-151.10.1007/978-3-642-56553-3_1Search in Google Scholar

18. Mormone E., George J., Nieto N.: Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chem Biol Interact., 30, 193, 3, 2011:225-231, doi: 10.1016/j.cbi.2011.07.001.10.1016/j.cbi.2011.07.001Search in Google Scholar

19. Page A. et al.: Alcohol directly stimulates epigenetic modifications in hepatic stellate cells. J Hepatol., 62, 2, 2015: 388-397, doi: 10.1016/j.jhep.2014.09.033.10.1016/j.jhep.2014.09.033Search in Google Scholar

20. Plewka K., Szuster-Ciesielska A., Kandefer-Szerszeń M.: Rola komórek gwiaździstych w procesie alkoholowego włóknienia wątroby (Role of stellate cells in alcoholic liver fibrosis) Postepy Hig Med Dosw., 63, 2009: 303-317.Search in Google Scholar

21. Suh Y.G., Jeong W.I.: Hepatic stellate cells and innate immunity in alcoholic liver disease. World J Gastroenterol, 28,17,20, 2011: 2543-2451, doi: 10.3748/wjg.v17.i20.2543.10.3748/wjg.v17.i20.2543Search in Google Scholar

22. Szantova M., Kupcova V.: Biochemical markers of fibrogenesis in liver diseases. Bratisl Lek Listy, 100,1, 1999: 28-35.Search in Google Scholar

23. Tomanovic N.R. et al.: Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study. J Gastrointestin Liver Dis., 18, 2, 2009: 163-167.Search in Google Scholar

24. Tsukamoto H. et al.: Roles of oxidative stress in activation of Kupffer and Ito cells in liver fibrogenesis. J Gastroenterol Hepatol., 10, 1, 1995:S50-S53.10.1111/j.1440-1746.1995.tb01798.xSearch in Google Scholar

25. Tsukamoto H.: Oxidative stress, antioxidants and alcoholic liver fibrogenesis. Alcohol., 10,6, 1993:465-467.10.1016/0741-8329(93)90066-WSearch in Google Scholar

26. Wan J. et al.: M2 kupffer cells promote hepatocyte senescence: an IL-6-dependent protective mechanism against alcoholic liver disease. Am J Pathol. 184,6, 2014:1763-1772, doi: 10.1016/j.ajpath.2014.02.014.10.1016/j.ajpath.2014.02.01424713392Search in Google Scholar